Atlas Trials

Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors

Clinical trial NCT01334073 · COMPLETED

Trial details

NCT number
NCT01334073
Sponsor
University Hospital, Bordeaux
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Advanced Solid TumorsCarcinoma, Renal Cell
Start date
2011-03-01
Primary completion
2013-05-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.